- EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
- EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
- EQS-AFR: Sartorius AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
- EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1207 preference shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1500 ordinary shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
More ▼
Key statistics
On Wednesday, Sartorius AG (SRTX:GER) closed at 180.80, 5.36% above its 52-week low of 171.60, set on Jun 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 177.00 |
---|---|
High | 182.20 |
Low | 177.00 |
Bid | 181.60 |
Offer | 182.00 |
Previous close | 177.40 |
Average volume | 6.11k |
---|---|
Shares outstanding | 74.88m |
Free float | 32.69m |
P/E (TTM) | 81.40 |
Market cap | 14.86bn EUR |
EPS (TTM) | 2.18 EUR |
Annual div (ADY) | 0.73 EUR |
---|---|
Annual div yield (ADY) | 0.41% |
Div ex-date | Apr 02 2024 |
Div pay-date | Apr 04 2024 |
Data delayed at least 15 minutes, as of Jun 26 2024 16:35 BST.
More ▼